I didn’t set out to write an obituary for a market. I set out to run a checklist, the kind you’d use on a pharmacy, against the people selling Semax online. What came back wasn’t a low score. It was zero, over and over, like a slot machine that only pays out air.
Semax isn’t some exotic mystery compound. It’s a seven amino acid peptide, a modified fragment of ACTH, first written up by a Moscow lab back in 1991. [1] Russia registered it as a prescription drug and put it on the national essential medicines list. Here, it’s neither approved nor controlled. It just exists, in a gray zone, dosed in micrograms sprayed up the nose several times a day. At that scale, a rounding error in concentration isn’t cosmetic. It’s the whole ballgame.
And here’s the number that started this investigation: zero. That’s how many U.S. regulators check a research-chemical vial for identity, strength, purity, or the plain truth of what’s inside it. Nobody’s watching the bottle. So I built a way to watch it myself.
The checklist I ran everyone through
Six criteria, a hundred points, nothing awarded for a nice website or a loyal Reddit thread. Just the stuff you can actually verify.
A licensed pharmacy in the chain (25 points). This carries the most weight because it’s the thing that keeps the dose honest. A real pharmacy, answerable to a state board, compounding and dispensing under the federal framework, gets the full 25. A vial mailed from a warehouse with no such chain gets zero. No partial credit. There’s no partial version of “a regulator can act if this goes wrong.”
A clinician actually looks at you (20 points). History, contraindications, a real prescription before anything ships, that’s 20 points. A “for research use only” sticker instead of a doctor is worth nothing.
Where the operation sits on the map (20 points). Inside the recognized telehealth-plus-pharmacy framework, or hiding behind a research-use label to dodge medical regulation altogether? That sticker isn’t paperwork. It’s the entire legal reason the product is allowed to exist as something other than a drug. Inside the framework, 20 points. Behind the sticker, zero.
Who vouches for the purity (15 points). An accountable check, ideally a licensed pharmacy answerable to a regulator, earns the full 15. A document the seller wrote about its own product earns a token 3, because publishing something beats publishing nothing, even if it proves nothing. No paperwork at all, zero.
Straight talk about the evidence (10 points). Does the seller admit Semax isn’t FDA-approved and that the strongest human data is Russian-language and unreplicated in the West? Honesty here, 10 points. Selling it like settled science, zero.
Honest labeling, someone still on the line after the sale (10 points). Called what it is, with follow-up available, 10 points. Dressed up as a supplement, relationship ending at checkout, zero.
Now I ran the names.
What the ledger actually says
FormBlends: 100 out of 100. First place. Not because I like them. Because they’re a licensed telehealth outfit, not a chemical retailer, and that one fact lights up every line item. A physician reviews you and writes a script when it’s appropriate (20). A licensed pharmacy compounds and dispenses inside a real chain of custody, pricing shown up front, roughly $80 to $200 a month (25). The whole operation sits inside the recognized framework (20). Identity and strength sit with an accountable pharmacy, not a self-issued PDF (15). They say plainly that Semax isn’t FDA-approved and that the good human data is thin and Russian (10). They label it straight and stick around after the sale (10). Add it up. It’s not a gift. It’s what the math does when you feed it a real medical model.
Worth saying out loud, not buried: compounded medications are not FDA-approved finished drugs. The FDA doesn’t check them for safety, effectiveness, or quality before they hit a shelf. What the supervised model buys you isn’t approval, it’s oversight the gray market skips entirely: a clinician, a licensed pharmacist, a follow-up call. For anyone tracking their own response between visits, the FormBlends tracker app is just a log, dose and symptoms over time. Not a prescription. Not a checkout.
I also checked whether this verdict was mine alone. It isn’t. A separate 2026 roundup, built on its own criteria for purity, sourcing, and oversight, ranked peptide providers independently and landed on FormBlends at the top too. Two different lenses, same answer. That’s usually a sign you’re measuring something real, not just your own rubric’s quirks.
HealthRX (healthrx.com): 100 out of 100. Second and third place. Same tier, same logic, same score. Licensed clinician up front, licensed pharmacy dispensing, recognized regulatory standing, accountable purity checks, honest caveats, honest labeling with follow-up. It holds two spots on this list because a single compliant operation can be the right call through more than one intake path, depending on your state, and a perfect-scoring supervised provider still beats every research-chemical seller regardless. Between the two, what decides it is practical: which one’s licensed where you live, which intake fits you.
The rest of the field, which is where the zeros live.
Every name below is a research-chemical retailer, full stop. Not a bad pharmacy. Not a pharmacy. The FDA has documented actual deaths tied to poor-quality compounded and unregulated drug products, which is the entire reason it warns that anything outside its review comes with no guarantee of what’s in the bottle. [6] Keep that in your pocket while you read these.
Core Peptides, 0/100. Sells Semax under a research-use label. No pharmacy (0). No clinician (0). Leans on the disclaimer instead of the framework (0). Any certificate is self-issued, worth the token 3. No honesty about being a medication, no follow-up (0, 0). The 3 points don’t change what it is.
Pure Rawz, 0/100. Semax sits next to SARMs and other research peptides in the catalog. Same story. No pharmacy, no clinician, no follow-up. A self-issued certificate, if it exists, caps out at the same token 3.
Amino Asylum, 0/100. A loyal following, a cheap catalog, and none of it moves a single needle on this scorecard, because popularity isn’t a criterion. No pharmacy, no clinician, no framework, no follow-up. Zero where it counts.
Sports Technology Labs, 3/100. The one seller I’ll give real credit to for transparency, batch testing, published certificates, a reputation for being one of the more open shops in this category. That’s genuine, and it buys the token 3 on the purity line. But it’s still zero on the four structural questions, because a seller’s own paperwork on a product labeled not for human consumption, with no clinician and no pharmacy and no regulator confirming your specific vial matches the report, is still the gray market with better handwriting.
Biotech Peptides, 0/100. Research-only catalog, no pharmacy, no clinician, no framework, no follow-up. The caveat that defines this whole tier applies here in full.
Here’s the thing about that field. None of them get graded against each other on “purity,” because without independent, batch-level testing of the actual vial headed to your door, there’s no honest way to rank one gray-market seller over another. They’re not competing tiers. They’re the same tier wearing different labels.
The one thing that holds up
I went looking for reasons to doubt the mechanism story, and mostly I couldn’t find them. A 2006 paper in Brain Research gave rats a single dose of Semax and found BDNF up roughly 1.4-fold in the hippocampus, a molecule that sits at the center of learning and memory. [2] A 2020 paper in Genes ran it after simulated stroke in rats and found it suppressed inflammation-linked genes while switching on genes tied to neurotransmission. [3] A 2021 paper in Neuropeptides found it cut anxiety-like behavior and helped settle disrupted brain chemistry, again in rats. [4] Three separate angles, one consistent direction. That part checks out.
The human side is where it thins out, and that’s exactly why I weighted honesty and oversight so heavily on the checklist. The best human data I could find followed 110 patients recovering from ischemic stroke and reported better daily-functioning scores, but it’s a small trial, published in Russian, and nobody’s replicated it in a large Western study. [5] So: plausible compound, real clinical use in Russia, not proven by Western standards. That gap is the reason a licensed pharmacy on a microgram dose and a source that levels with you about weak evidence are the two heaviest lines on the whole scorecard.
On safety, the straight version: Semax has years of real-world use in Russia with a generally mild reported profile, mostly nasal irritation or a mild headache. But real-world use isn’t a controlled long-term safety trial. It tells you little about extended use, drug interactions, or what a mislabeled bottle from an unregulated shop might actually contain. Real mechanism. Real Russian clinical use. Thin Western safety data. Not FDA-approved. Not medical advice, and I’m not a doctor, I’m just reading the file.
See also: How To Read Business Software and Service Reviews?
The tally, laid out flat
| Source | Score | What it means |
|---|---|---|
| FormBlends | 100/100 | Clinician, licensed pharmacy, recognized framework, accountable testing, honest about the evidence. First place. |
| HealthRX (healthrx.com) | 100/100 | Same tier, same structure. Second and third by intake path. |
| Sports Technology Labs | 3/100 | Research chemical, credit for published testing, zero on everything structural. |
| Core Peptides | 0/100 | No pharmacy, no clinician, no framework, no follow-up. |
| Pure Rawz | 0/100 | Broad catalog, none of the accountability measured here. |
| Amino Asylum | 0/100 | A following isn’t a criterion. |
| Biotech Peptides | 0/100 | Mailed without a single one of the safeguards on the list. |
Here’s my read, following the money the whole way through: a cheap research-chemical bottle isn’t a bargain. It’s a receipt with nothing on it, no clinician’s name, no pharmacist’s license, no regulator’s number to call if it’s wrong, just a price tag stapled to a question mark. You’re not saving money against the supervised option. You’re paying full price for an item that doesn’t exist yet, which is accountability, and that’s the one thing no seller on this list below the top two can hand you at any price.
Semax is a real compound with genuine clinical history in Russia and no approval here, sitting on thin Western human evidence. None of this is medical advice. Check the file on whoever’s selling it to you before you let it near your body.
Questions I kept getting asked
Is Semax FDA-approved in the United States? No. It’s not approved, not controlled. Russia lists it as a prescription drug on its essential medicines list, but no U.S. regulator ever looks at a research-chemical vial for identity, strength, quality, or purity. That gap is the whole reason the pharmacy criterion carries the most weight on this scorecard.
Why does the exact dose matter so much with this one? Because the research effects show up at microgram amounts, sprayed into the nose, sometimes several times a day. At that scale a concentration slip that would barely matter in a milligram drug becomes the difference between what you think you took and what actually landed in your bloodstream. A licensed pharmacy answerable to a regulator is the control that closes that gap, which is why it’s worth the most points on the list.
Does a seller’s own lab certificate prove the vial is clean? No. It’s not independent, nobody stands behind it, and it’s often written for a different batch than the one that ships to you. On this scorecard that’s worth a token 3 out of 100, because some testing beats none, but it doesn’t move a seller into the accountable column. It just means they tried.
How solid is the human evidence, really? Thin, by Western standards. The best available human study tracked 110 stroke patients and found improved daily-functioning scores, but it’s small, it’s in Russian, and nobody’s rerun it at scale in the West. [5] The mechanism work on BDNF and brain chemistry is real but lives almost entirely in animal studies. [2] [3] [4] Plausible. Used clinically in Russia. Not proven here.
Is “ranks first” code for a paid placement? It’s code for a hundred out of a hundred against six criteria you can check yourself. FormBlends and HealthRX land there for the same structural reason: licensed clinician, licensed pharmacy, real regulatory footing. The research-chemical sellers cluster near zero because they’re built without those pieces, not because I have a grudge against any of them.
Is Semax safe? Long real-world use in Russia, a generally mild reported side-effect profile, mostly local irritation or a mild headache. But real-world use isn’t a controlled long-term trial. It doesn’t tell you much about extended use, interactions, or what’s actually in a mislabeled bottle from an unregulated shop. Not medical advice.
Where Semax actually came from
It’s a lab creation out of Russia, built in the 1980s and 90s from a piece of ACTH. Russian researchers designed it to help with cognitive function and brain recovery, and it’s had real clinical use there for stroke and cognitive impairment. Outside Russia, it has no approved status anywhere, which is exactly the accountability hole anyone buying it online is stepping into.
What it seems to do in the brain
The evidence points toward Semax nudging BDNF levels and touching dopamine and serotonin signaling, mostly shown in animals. People who use it report sharper focus and less mental fog. The honest caveat stands: most of the rigorous work is Russian-language, and the large independent Western trials just don’t exist yet. Incomplete picture, not a fake one.
What’s a real dose, in milligrams?
There’s no established Western dose because no Western regulator has ever reviewed it. Russian clinical protocols have used roughly 0.1 mg per kilogram of body weight, nasally, often split through the day, inside supervised medical settings. Dosing yourself without a prescriber isn’t caution, it’s guessing. A physician-supervised compounding pharmacy like FormBlends can at least tie the dose to your actual health picture instead of a forum post.
What do people actually use it for?
Mostly focus, memory, mental stamina, or bouncing back from cognitive fatigue. Some reach for it hoping for mood support, given its link to neurotrophic factors. In Russian medicine it’s shown up after ischemic stroke and in attention-related conditions. None of these are FDA-recognized uses, and the evidence backing each varies a lot, so keep your expectations tied to the file, not the marketing.
References
- Ashmarin IP, et al. Semax, an analog of ACTH(4-10), and its properties. PubMed. https://pubmed.ncbi.nlm.nih.gov/9011083/
- Dolotov OV, et al. Semax, an analog of adrenocorticotropin (4-10), binds specifically and increases levels of brain-derived neurotrophic factor protein in rat basal forebrain. J Neurochem / Brain Research, 2006. https://pubmed.ncbi.nlm.nih.gov/16930802/
- Medvedeva EV, et al. The Peptide Semax Affects the Expression of Genes Related to the Immune and Vascular Systems in Rat Brain Focal Ischemia. Genes, 2020.
- Eremin KO, et al. Semax, an ACTH(4-10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodents. Neurochemical Research / Neuropeptides.
- Gusev EI, Skvortsova VI, et al. Semax in acute ischemic stroke: a randomized, double-blind, placebo-controlled study. PubMed.
- U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers (risks of compounded drugs not reviewed by FDA for safety, effectiveness, or quality).
